CIK: 0001856083 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $2,381,793 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IMVT | IMMUNOVANT INC | 9,710,000 | $172,353 | 7.2% | $6.72 | +87.3% | COM | 45258J102 |
| — | IVERIC BIO INC | 7,878,119 | $168,671 | 7.1% | $17.64 | — | COM | 46583P102 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 873,553 | $139,166 | 5.8% | $140.42 | +4.4% | SHS USD | G50871105 |
| TVTX | TRAVERE THERAPEUTICS INC | 4,582,000 | $96,359 | 4.0% | $26.53 | -20.1% | COM | 89422G107 |
| ASND | ASCENDIS PHARMA A/S | 700,000 | $85,491 | 3.6% | $103.26 | — | SPONSORED ADR | 04351P101 |
| INSM | INSMED INC | 4,264,292 | $85,201 | 3.6% | $19.33 | 0.0% | COM PAR $.01 | 457669307 |
| BCYC | BICYCLE THERAPEUTICS PLC | 2,819,045 | $83,444 | 3.5% | $40.57 | — | SPONSORED ADS | 088786108 |
| — | VERONA PHARMA PLC | 3,187,415 | $83,287 | 3.5% | $12.01 | — | SPONSORED ADS | 925050106 |
| BIIB | BIOGEN INC | 300,000 | $83,076 | 3.5% | $282.44 | 0.0% | COM | 09062X103 |
| — | SPRINGWORKS THERAPEUTICS INC | 3,109,886 | $80,888 | 3.4% | $27.93 | — | COM | 85205L107 |
| — | CHINOOK THERAPEUTICS INC | 3,000,000 | $78,600 | 3.3% | $16.47 | — | COM | 16961L106 |
| SRPT | SAREPTA THERAPEUTICS INC | 528,244 | $68,450 | 2.9% | $115.88 | 0.0% | COM | 803607100 |
| — | AGENUS INC | 27,000,000 | $64,800 | 2.7% | $2.24 | — | COM NEW | 00847G705 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2,656,901 | $59,010 | 2.5% | $19.53 | -20.9% | COM | 35104E100 |
| — | HORIZON THERAPEUTICS PUB L | 500,000 | $56,900 | 2.4% | $61.89 | — | SHS | G46188101 |
| — | HORIZON THERAPEUTICS PUB L | 500,000 | $56,900 | 2.4% | $61.89 | — | Put | G46188101 |
| — | DICE THERAPEUTICS INC | 1,734,143 | $54,105 | 2.3% | $27.80 | — | COM | 23345J104 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,771,154 | $51,735 | 2.2% | $18.36 | +25.5% | COM | 92790C104 |
| — | 89BIO INC | 3,850,000 | $49,011 | 2.1% | $7.98 | — | COM | 282559103 |
| BEAM | BEAM THERAPEUTICS INC | 1,166,473 | $45,621 | 1.9% | $63.62 | -29.6% | COM | 07373V105 |
| IONS | IONIS PHARMACEUTICALS INC | 1,205,773 | $45,542 | 1.9% | $42.06 | 0.0% | COM | 462222100 |
| — | ALLAKOS INC | 4,899,179 | $41,251 | 1.7% | $6.30 | — | COM | 01671P100 |
| — | REPARE THERAPEUTICS INC | 2,727,606 | $40,123 | 1.7% | $18.55 | — | COM | 760273102 |
| — | ALBIREO PHARMA INC | 1,704,000 | $36,823 | 1.5% | $20.14 | — | COM | 01345P106 |
| PLRX | PLIANT THERAPEUTICS INC | 1,732,946 | $33,498 | 1.4% | $19.47 | +7.4% | COM | 729139105 |
| DYN | DYNE THERAPEUTICS INC | 2,684,200 | $31,110 | 1.3% | $12.14 | -4.7% | COM | 26818M108 |
| ASND | ASCENDIS PHARMA A/S | 249,300 | $30,447 | 1.3% | $103.26 | — | Call | 04351P101 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,374,394 | $30,167 | 1.3% | $10.10 | -7.2% | COM | 28036F105 |
| SLN | SILENCE THERAPEUTICS PLC | 1,951,580 | $29,762 | 1.2% | $16.79 | — | ADS | 82686Q101 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 15,000,000 | $28,500 | 1.2% | $1.90 | — | SPON ADS | 05280R100 |
| — | ASTRIA THERAPEUTICS INC | 1,816,531 | $27,048 | 1.1% | $14.89 | — | COM | 04635X102 |
| — | VIGIL NEUROSCIENCE INC | 2,104,174 | $26,302 | 1.1% | $8.83 | — | COM | 92673K108 |
| — | RAPT THERAPEUTICS INC | 1,304,940 | $25,838 | 1.1% | $19.80 | — | COM | 75382E109 |
| ESPR | ESPERION THERAPEUTICS INC NE | 4,000,000 | $24,920 | 1.0% | $7.78 | -8.1% | COM | 29664W105 |
| NRIX | NURIX THERAPEUTICS INC | 2,266,569 | $24,887 | 1.0% | $11.40 | +5.8% | COM | 67080M103 |
| — | DYNAVAX TECHNOLOGIES CORP | 2,327,951 | $24,769 | 1.0% | $10.64 | — | COM NEW | 268158201 |
| NTLA | INTELLIA THERAPEUTICS INC | 700,000 | $24,423 | 1.0% | $53.76 | -11.6% | COM | 45826J105 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 3,952,000 | $21,341 | 0.9% | $8.05 | -16.5% | COM | 00509G209 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 189,800 | $19,642 | 0.8% | $80.70 | +16.3% | COM | 09061G101 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,048,829 | $19,194 | 0.8% | $24.65 | -28.5% | COM | 22663K107 |
| GERN | GERON CORP | 7,414,693 | $17,944 | 0.8% | $2.24 | 0.0% | COM | 374163103 |
| HRTX | HERON THERAPEUTICS INC | 6,496,976 | $16,242 | 0.7% | $3.91 | -17.7% | COM | 427746102 |
| NUVB | NUVATION BIO INC | 8,221,188 | $15,785 | 0.7% | $4.49 | -54.9% | COM CL A | 67080N101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 500,000 | $12,725 | 0.5% | $23.32 | 0.0% | COM | 87164F105 |
| RLMD | RELMADA THERAPEUTICS INC | 2,837,818 | $9,904 | 0.4% | $10.86 | -19.1% | COM | 75955J402 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 871,493 | $9,508 | 0.4% | $8.44 | 0.0% | COM | 74366E102 |
| NKTX | NKARTA INC | 1,354,200 | $8,112 | 0.3% | $14.20 | -28.9% | COM | 65487U108 |
| RNAM | AVIDITY BIOSCIENCES INC | 300,000 | $6,657 | 0.3% | $14.91 | 0.0% | COM | 05370A108 |
| VKTX | VIKING THERAPEUTICS INC | 610,083 | $5,735 | 0.2% | $4.46 | 0.0% | COM | 92686J106 |
| FULC | FULCRUM THERAPEUTICS INC | 768,607 | $5,595 | 0.2% | $16.30 | -60.0% | COM | 359616109 |
| GHRS | GH RESEARCH PLC | 499,400 | $4,854 | 0.2% | $21.97 | -50.8% | ORDINARY SHARES | G3855L106 |
| — | JOUNCE THERAPEUTICS INC | 4,259,653 | $4,728 | 0.2% | $8.25 | — | COM | 481116101 |
| IPSC | CENTURY THERAPEUTICS INC | 695,845 | $3,570 | 0.1% | $14.74 | -36.0% | COM | 15673T100 |
| — | INOZYME PHARMA INC | 3,250,000 | $3,413 | 0.1% | $4.77 | — | COM | 45790W108 |
| — | ASSEMBLY BIOSCIENCES INC | 1,833,437 | $2,383 | 0.1% | $2.33 | — | COM | 045396108 |
| — | THIRD HARMONIC BIO INC | 445,572 | $1,916 | 0.1% | $18.97 | — | COM | 88427A107 |
| AUPH | AURINIA PHARMACEUTICALS INC | 324,238 | $1,401 | 0.1% | $8.66 | -33.0% | COM | 05156V102 |
| — | MAGENTA THERAPEUTICS INC | 3,000,000 | $1,185 | 0.0% | $4.29 | — | COM | 55910K108 |
| — | HOOKIPA PHARMA INC | 1,240,369 | $1,005 | 0.0% | $2.28 | — | COM | 43906K100 |
| — | REATA PHARMACEUTICALS INC | 12,600 | $479 | 0.0% | — | — | Call | 75615P103 |